USPSTF: Don't Routinely Screen Pregnant Women for Bacterial Vaginosis
By News Staff
3/4/2008
The guidance related to pregnant women at high risk for preterm delivery is considered an "I" statement, meaning that the USPSTF has concluded "that the current evidence is insufficient to assess the balance of benefits and harms of the service. Evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined." Again, the task force found no direct evidence indicating that screening for bacterial vaginosis reduces adverse health outcomes in these women; and evidence from good-quality studies on the benefits of treating the condition is conflicting.
The USPSTF found only poor evidence regarding potential harms of screening for bacterial vaginosis in either group of pregnant women; studies in this area were lacking. However, task force members found fair evidence that false-positive results from screening asymptomatic women at low risk for preterm delivery can lead to harms associated with treatment. They found conflicting evidence regarding the harms of treating the condition in asymptomatic women at high risk for preterm delivery.
According to the "Clinical Considerations" section of the USPSTF recommendation statement, specific risk factors for preterm delivery include "African-American race or ethnicity," low body mass index, vaginal bleeding, previous preterm delivery, pelvic infection and bacterial vaginosis. Bacterial vaginosis, the most common lower genital tract syndrome among women of reproductive age, is most frequently seen in black women, women of lower socioeconomic status and those who previously have delivered low-birthweight babies.
Studies have documented an association between bacterial vaginosis and preterm delivery, and it is this epidemiologic evidence that for years had been used as a rationale for screening asymptomatic pregnant women for the disease -- despite the fact that as many as half of all cases resolve spontaneously during pregnancy.
New ACIP Provisional Recs Cover Multiple Vaccine Topics
FDA Panel Recommends Acetaminophen Restrictions
ACIP Gives Thumbs-up to New Antiviral Recs
CDC Reinstates Hib Booster for 12- to 15-month-olds
Committee Recommends A1c Testing for Diabetes Diagnosis
CDC Urges Health Workers to Avoid H1N1 Infection
WHO Declares Pandemic, But Little Else Changes
AAFP Posts New Pregnancy-related Clinical Services Recommendations
Thyroid Drug Linked to Liver Injury, FDA Warns
IOM Updates Guidelines for Weight Gain in Pregnancy
Manufacturers to Begin Work on H1N1 Vaccine
Role of FPs in Prenatal Care Declining Even in Rural Areas
CDC Considering Early Start to Flu Vaccinations
CDC Urges Docs Not to Hoard Hep B Vaccine Doses
H1N1 Flu: CDC Updates Antiviral Guidance
FDA Requiring Label Changes for Botox Products








